President Pharmaceuticals Mission Pharmacal
About Terrell Herring
Terrell Herring, currently President of Commercial Operations, Mission Pharmacal, leads a long and successful career in the pharmaceutical industry. Mr. Herring graduated cum laude from The Citadel, Military College of South Carolina in Charleston, with a Bachelor of Science in Biology and went on to earn a Master of Business Administration. Additional training that Terrell Herring has completed includes a graduate certificate in Project Design from the Mercer University School of Engineering and a graduate certificate at the International Marketing forum of Duke University and London Business School.
In addition to his work with Mission, Terrell Herring has collaborated with inVentiv Health, where he held the position of President and Chief Operating Officer (COO), and inVentiv Commercial Services, which he ran as President and Chief Executive Officer (CEO). Mr. Herring additionally served in leadership roles with Noven Pharmaceuticals, Solvay Pharmaceuticals, and Ciba-Geigy Pharmaceuticals. Mr. Herring has earned several professional awards throughout his career, including mentions in PharmaVOICE's Top 100 Most Inspiring People in the Life Sciences for two consecutive years. In 2008, inVentiv earned recognition in Training Magazine's Top 125 Companies list.
During his unoccupied time, Terrell Herring enjoys driving sports cars, operating Cobalt boats, and motorcycling. He additionally sets aside time for reading historical and biographical nonfiction. In 2007, he published the manuscript Marching Orders for Leadership Success: Inspired by My Hero Stonewall Jackson, a personal achievement guide that coaches readers in developing their leadership skills.
A Big Brothers Big Sisters supporter since 1993, Terrell Herring earned recognition as an Honoree of the organization in 2007. He is additionally a former Board Member at Camp Kirkwood, a spiritual camp for young people. Alongside his contributions at Mission Pharmacal, he serves on the Archway Marketing Services, Inc., Advisory Board.
Adding a Spiritual Dimension to Leadership When Results Falter
Terrell “Terry” Herring is a Pennsylvania-based professional who is the president of Texas-based Mission Pharmacal Company’s commercial operations. He also leads the Mission Family of Companies subsidiary, Alamo Pharma Services. Terrell Herring maintains board membership with A New Equilibrium (ANE), a nonprofit that seeks out strategic leadership pathways with a spiritual dimension.
A recent ANE Leadership Insight article focused on the concept that effective leadership is tied to the ability to create motivated teams that strive to “deliver great results.” Unfortunately, during times when the economic engine falters, the tendency is to radiate a sense of I-focused fear, with worries of leadership accountability and responsibility for missteps coming to the fore. At just the moment when new ideas are required, fear takes over and prevents the kinds of innovation that could enable growth.
Once a spiritual dimension is added to the picture, everything changes, with corporate actions being undertaken with a well-defined purpose in mind. Rather than viewing the internal corporate landscape as a zero-sum end game, the leader seeks to create a sense of unity and organizational wholeness that puts team members on the same productive page once again.
March of Babies Offers Helpful Zika Fighting Tips to Protect Infants
As president of commercial operations at Mission Pharmacal Company and president of Alamo Pharma Services, Terrell Herring is a leader in prescription medication development. In addition to his dedication to healthcare, Terrell (Terry) Herring and his companies support the efforts of the March of Dimes and March for Babies.
The March of Dimes is a leader in the fight for the health of mothers and infants. The organization is especially active in combating premature birth, the leading cause of infant death around the world. To expand research efforts and healthcare services for premature babies, the March of Dimes operates March for Babies events in 500 communities each year.
In light of the recent Zika scare, March for Babies has published helpful tips to keep expecting mothers and their babies safe. Consider these tips to stop Zika and protect infants.
- Use EPA-approved insect repellents and protective clothing.
- Keep screens on windows, and use air conditioning when necessary.
- Remove still or standing water on your property.
- Avoid sexual transmission of Zika by practicing safe sex.
- Visit your doctor if you suspect you have been exposed to the Zika virus.
Things to Consider When Purchasing Golf Balls
The president of commercial operations at Mission Pharmacal since 2010, Terrell Herring works closely with the ownership team to shape the strategic future of the company. Also serving active roles in other Mission Family of Companies entities, including BioComp Pharmaceuticals, BexR Logistix, and Epic Fulfillment, Terrell Herring brings years of leadership experience to his work. In his spare time, he enjoys playing golf and can often be found on the course with his friends.
The golf ball is one of the most important pieces of equipment in your setup, so it is important to choose the right one for your playing style. When buying balls, consider details, such as:
1. Dimples. The size and depth of the dimples affect how high the ball will travel, with short, deep dimples generally resulting in less height.
2. Core. A large core allows for the generation of more speed in shots, whereas stiff cores are ideal for players who want to generate more spin.
3. Layers. The more layers a ball has, the more control the ball provides to the player. However, hitting balls that have three or four layers requires additional expertise. Novices are advised to use two-layer golf balls.
4. Cover. You will usually be presented with a choice of urethane and Surlyn for the cover. Surlyn is harder, making it ideal for distance shots, whereas urethane offers more control due to its softer and thinner characteristics.
Sixers First Overall Pick Sidelined to Start Career
Terrell "Terry" Herring serves as president of commercial operations for Mission Pharmacal Company and president of its subsidiary company, Alamo Pharma Services, based in Doylestown, Pennsylvania. When he isn't focused on expanding both company's presence in the healthcare sector, Terrell Herring enjoys attending live sporting events for his favorite Philadelphia sports teams, such as the NBA's 76ers.
After winning the 2016 NBA Draft Lottery last season, the 76ers appeared to significantly improve their team with the selection of Australian forward Ben Simmons. Unfortunately, Simmons has yet to play a single NBA game and, in February, was ruled out for the remainder of the season with a foot injury. Just weeks before the start of the 2016-17 season, Simmons broke a bone in his right foot, and although he was originally only expected to miss a few months, his foot hasn't healed as expected.
A player missing his entire rookie season is nothing new for the 76ers. Nerlens Noel, who the team recently traded to the Dallas Mavericks, missed his rookie year due to injury, and Joel Embiid missed his first two seasons due to a foot injury and was recently sidelined for the remainder of the 2016-17 season.
Napo and Alamo Join Forces to Launch Mytesi National Sales Force
An experienced pharmaceutical industry executive, Terrell Herring serves as the president of Alamo Pharma Services, Inc., in Doylestown, Pennsylvania. Recently, Terrell (“Terry”) Herring and his team announced a partnership with Napo Pharmaceuticals, Inc., to launch a national sales force for Mystesi.
Last October, Napo, which develops and commercializes pharmaceuticals derived from tropical plants, launched Mytesi (formerly known as Fulyzaq), an FDA-approved drug for the symptomatic relief of noninfectious diarrhea among adults who are on antiretroviral therapies for HIV/AIDS. Nearly 80 percent of clinical trial participants experienced relief over a four-week period.
Alamo has agreed to provide a team of sales representatives to supplement the Napo team and bring samples of Mytesi to key metropolitan areas in the United States. The sales strategy involves contacting physicians who treat large populations of patients with HIV who could benefit from the drug. In areas not covered by sales representatives, Alamo will provide telesales support.
The potential American market for Mytesi has been approximated at $100 million in gross annual sales. In 2017, Napo expects the drug to generate about $7 million in net sales.
BBBSA Awards Grants to Bigs in Blue Participants
Experienced pharmaceutical executive Terrell Herring serves as the president of commercial operations at Mission Pharmacal Company and president of Alamo Pharma Services, Inc. Apart from his day-to-day work, Terrell (“Terry”) Herring has supported many charitable causes, including Big Brothers Big Sisters of America (BBBSA).
As part of its Bigs in Blue initiative, BBBSA recently announced the nationwide distribution of 13 different grants to various law enforcement organizations taking part in the program. In total, it awarded $560,000 in grants to these agencies.
The Bigs in Blue program engages law enforcement personnel and encourages them to become mentors in BBBSA programs. The grants will bolster these programs in areas such as officer mentorship training and expanded recruiting efforts. In her comments, BBBSA President and CEO Pam Iorio lauded the positive outcomes the program has already generated nationwide, stressing the importance of strengthening the bond between local communities and the law enforcement agencies that serve them.